概念验证：微创 AngioVac 方法治疗伴心房血栓的肾细胞癌。

Proof of Concept: Microinvasive AngioVac Approach in Renal Cell Carcinoma With Atrial Thrombosis.

机构信息

Cardiac Surgery Unit, Department of Cardiac Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.

Urology Unit, Department of Surgical, Oncological, and Gastroenterological Sciences, University of Padova, Padova, Italy.

出版信息

Ann Thorac Surg. 2021 Sep;112(3):e193-e196. doi: 10.1016/j.athoracsur.2020.11.093. Epub 2021 Mar 4.

DOI:10.1016/j.athoracsur.2020.11.093

PMID:33676906

Abstract

The AngioVac system (AngioDynamics, Latham, NY) has already been described for treatment of thrombotic formations concerning the venous district and the tricuspid valve. We describe an innovative application of the AngioVac system to treat the inferior vena cava thrombosis associated with renal cell carcinoma. In a high surgical risk patient, we utilized a microinvasive and a modified venoarterial AngioVac circuit to remove the atrial thrombus, ensure temporary circulatory support during abdominal surgery, and prevent pulmonary embolism.

摘要

AngioVac 系统（AngioDynamics，纽约莱瑟姆）已经被描述用于治疗静脉区和三尖瓣的血栓形成。我们描述了一种创新性的 AngioVac 系统应用，用于治疗与肾细胞癌相关的下腔静脉血栓。在高手术风险的患者中，我们使用微创和改良的静脉动脉 AngioVac 回路来清除心房血栓，在腹部手术期间提供临时循环支持，并预防肺栓塞。